← SynDRA
INDIBULIN
SynDRA canonical compound SYN0002365 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
| Mechanism of action | tubulin polymerization inhibitor |
All known targets
- TUBA1A
- TUBA1B
- TUBA1C
- TUBA3C
- TUBA3E
- TUBA4A
- TUBB
- TUBB1
- TUBB2A
- TUBB2B
- TUBB3
- TUBB4A
Mechanisms of action (all sources)
- TUBB4B INHIBITOR
- TUBB1 INHIBITOR
- TUBA3C INHIBITOR
- TUBA4A INHIBITOR
- TUBB3 INHIBITOR
- TUBA1A INHIBITOR
- TUBB4A INHIBITOR
- TUBB8 INHIBITOR
- TUBB INHIBITOR
- TUBA1B INHIBITOR
- TUBA1C INHIBITOR
- TUBA3E INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CP2C9
- CP3A7
- TUBB8
- TUBB6
- TUBB4B
- TUBB4A
- TUBB3
- TUBB2B
- TUBB2A
- TUBB1
- TUBB
- TUBA4A
- TUBA3E
- TUBA3C
- TUBA1C
- TUBA1B
- TUBA1A
- TFE3
- SYK
- NSD2
- MITF
- KSYK
- IFNG
- YAP1
Cross-references
Synonyms
- Indibuline
- Indibulina
- D-24851
- ZIO-301
- 2-(1-(4-chlorobenzyl)-1H-indol-3-yl)-2-oxo-N-(pyridin-4-yl)acetamide
- D 24851
- UNII-80K4H2RB8P
- 80K4H2RB8P
- 2-[1-(4-chlorobenzyl)-1h-indol-3-yl]-2-oxo-n-(pyridin-4-yl)acetamide
- N-(Pyridin-4-yl)-[1-(4-chlorobenzyl)-indol-3-yl]-glyoxyl Amide
- Indibulin [USAN:INN]
- 2-{1-[(4-chlorophenyl)methyl]indol-3-yl}-2-oxo-N-(4-pyridyl)acetamide
- 2-[1-[(4-chlorophenyl)methyl]indol-3-yl]-2-oxo-N-(4-pyridyl)acetamide
- Indibulin (USAN/INN)
- AC1L1ESK
- AC1Q5NS8
- MLS006011745
- CHEMBL49642
- ZIO 301
- ZIO 301;D 24851
- 2-(1-(4-Chlorophenylmethyl)-1H-indol-3-yl)-2-oxo-N-(pyridin-4-yl)acetamide
- 2-[1-[(4-chlorophenyl)methyl]indol-3-yl]-2-oxo-N-pyridin-4-ylacetamide
- Indibulin [INN]
- 1H-Indole-3-acetamide, 1-((4-chlorophenyl)methyl)-alpha-oxo-N-4-pyridinyl-
- 1H-Indole-3-acetamide, 1-[(4-chlorophenyl)methyl]-alpha-oxo-N-4-pyridinyl-
- INDIBULIN [USAN]
- SCHEMBL3165856
- DTXSID70174368
- AMY21420
- BCP33949
- EX-A4542
- BDBM50510963
- MFCD05861105
- NSC758489
- STK783524
- ZINC37866151
- AKOS005619980
- D 24851ZIO 301
Look up INDIBULIN in the interactive SynDRA portal →